ConductScience.org, home

Paper19750010

O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Zhang X and 2 others. PLoS One, 2009. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. Papers, record 19750010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19750010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.
PubMed
Journal
PLoS One
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang XXuqing
2Rodríguez MEMaria Eugenia
3Harvill ETEric T

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
Bordetella parapertussisMajor topic
Bordetella pertussisMajor topic
O AntigensMajor topic
Pertussis VaccineMajor topic
Animals
Bordetella Infections
Interferon-gamma
Leukocytes, Mononuclear
Lung
Mice
Mice, Inbred C57BL
Phagocytosis
Protein Binding
Spleen

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI053075NIAID NIH HHSUnited StatesR01AI053075PubMed and NIHNIH RePORTER
R01 GM083113NIGMS NIH HHSUnited StatesR01GM083113PubMed and NIHNIH RePORTER
GM083113NIGMS NIH HHSUnited StatesR01GM083113PubMed and NIHNIH RePORTER

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117210665Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection.Infect Immun2007https://conductscience.org/library/papers/17210665PubMed
22906641Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material.J Clin Microbiol1988https://conductscience.org/library/papers/2906641PubMed
39607064The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.Vaccine1998https://conductscience.org/library/papers/9607064PubMed
415831828Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Clin Microbiol Rev2005https://conductscience.org/library/papers/15831828PubMed
59542925Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates.J Clin Microbiol1998https://conductscience.org/library/papers/9542925PubMed
616382131Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.Pediatrics2006https://conductscience.org/library/papers/16382131PubMed
716428751The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.Infect Immun2006https://conductscience.org/library/papers/16428751PubMed
89382883Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.J Exp Med1997https://conductscience.org/library/papers/9382883PubMed
911334963Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera.J Immunol Methods2001https://conductscience.org/library/papers/11334963PubMed
107475771Pertussis in adults: frequency of transmission after household exposure.Lancet1995https://conductscience.org/library/papers/7475771PubMed
1118285500O antigen protects Bordetella parapertussis from complement.Infect Immun2008https://conductscience.org/library/papers/18285500PubMed
1216557217
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep2006https://conductscience.org/library/papers/16557217PubMed
1312654784Role of antibodies in immunity to Bordetella infections.Infect Immun2003https://conductscience.org/library/papers/12654784PubMed
1411871441From the Centers for Disease Control and Prevention. Pertussis--United States, 1997-2000.JAMA2002https://conductscience.org/library/papers/11871441PubMed
1511714823Fc receptor-mediated immunity against Bordetella pertussis.J Immunol2001https://conductscience.org/library/papers/11714823PubMed
1616177324Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.Infect Immun2005https://conductscience.org/library/papers/16177324PubMed
171714327Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.Blood1991https://conductscience.org/library/papers/1714327PubMed
183584073Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.J Bacteriol1987https://conductscience.org/library/papers/3584073PubMed
1910417135Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae.Infect Immun1999https://conductscience.org/library/papers/10417135PubMed
204324651A simple chemically defined medium for the production of phase I Bordetella pertussis.J Gen Microbiol1970https://conductscience.org/library/papers/4324651PubMed

See all 51 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
38543887Pertussis Vaccines Scarcely Provide Protection against Bordetella parapertussis Infection in Children-A Systematic Review and Meta-Analysis.Vaccines (Basel)2024https://conductscience.org/library/papers/38543887PubMed
38011105Adenylate cyclase toxin of Bordetella parapertussis disrupts the epithelial barrier granting the bacterial access to the intracellular space of epithelial cells.PLoS One2023https://conductscience.org/library/papers/38011105PubMed
33178148Evolution and Conservation of Bordetella Intracellular Survival in Eukaryotic Host Cells.Front Microbiol2020https://conductscience.org/library/papers/33178148PubMed
31889098Enhancement of immune response against Bordetella spp. by disrupting immunomodulation.Sci Rep2019https://conductscience.org/library/papers/31889098PubMed
31744907Conserved Patterns of Symmetric Inversion in the Genome Evolution of Bordetella Respiratory Pathogens.mSystems2019https://conductscience.org/library/papers/31744907PubMed
31190311Bordetella bronchiseptica Glycosyltransferase Core Mutants Trigger Changes in Lipid A Structure.J Am Soc Mass Spectrom2019https://conductscience.org/library/papers/31190311PubMed
30976607Bordetella parapertussis Bacteremia: Clinical Expression and Bacterial Genomics.Open Forum Infect Dis2019https://conductscience.org/library/papers/30976607PubMed
30459769Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection.Front Immunol2018https://conductscience.org/library/papers/30459769PubMed
28514288Bordetella parapertussis outbreak in Southeastern Minnesota and the United States, 2014.Medicine (Baltimore)2017https://conductscience.org/library/papers/28514288PubMed
28095485Bordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms.PLoS One2017https://conductscience.org/library/papers/28095485PubMed
27716057Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species.BMC Genomics2016https://conductscience.org/library/papers/27716057PubMed
25422302Bordetella parapertussis PagP mediates the addition of two palmitates to the lipopolysaccharide lipid A.J Bacteriol2015https://conductscience.org/library/papers/25422302PubMed
25267839Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.Infect Immun2014https://conductscience.org/library/papers/25267839PubMed
23092514Lack of cross-protection against Bordetella holmesii after pertussis vaccination.Emerg Infect Dis2012https://conductscience.org/library/papers/23092514PubMed
23027528
Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.
Infect Immun2012https://conductscience.org/library/papers/23027528PubMed
21398615Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice.J Immunol2011https://conductscience.org/library/papers/21398615PubMed
20974829Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.Infect Immun2011https://conductscience.org/library/papers/20974829PubMed
20592026Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic.J Biol Chem2010https://conductscience.org/library/papers/20592026PubMed
20200027Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.Proc Biol Sci2010https://conductscience.org/library/papers/20200027PubMed
19737902The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.Infect Immun2009https://conductscience.org/library/papers/19737902PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19750010

GET https://conductscience.org/api/papers/v1/19750010/references?page=2